Initial Treatment for Ulcerative Colitis

Treatment Algorithm

The American Gastroenterological Association suggests starting with combination therapy of oral mesalamine 2.4-4.8 g/day plus rectal mesalamine 1 g/day as first-line treatment to maximize remission rates for patients with ulcerative colitis extending beyond the rectum with mild disease activity 1, 2
Oral mesalamine should be started with 2.4-3 g/day as the standard dose, with the option to use up to 4.8 g/day for patients with moderate activity or if standard dosing proves insufficient, according to the Toronto Consensus guidelines 1, 3
Rectal mesalamine should be added at least 1 g/day as an enema to improve efficacy in patients with disease extending beyond the rectum, as recommended by the American Gastroenterological Association 1, 2
Once-daily dosing of mesalamine is as effective as divided doses and improves adherence, based on evidence from the Gastroenterology journal 4, 2

The Toronto Consensus guidelines suggest combination oral and rectal 5-ASA over oral 5-ASA alone as an alternative first-line therapy for disease beyond proctitis, though this is a weak recommendation based on low-quality evidence 1
For left-sided colitis, combined therapy with mesalamine enema plus oral mesalamine is optimal and superior to monotherapy, according to the Praxis Medical Insights guidelines 2

Assess response at 4-8 weeks to determine need for therapy modification, as recommended by the American Gastroenterological Association 1, 4
If inadequate response, first escalation should be to increase to high-dose oral mesalamine (4.8 g/day) with continued rectal mesalamine, based on guidelines from the Praxis Medical Insights 2
Second escalation, if still inadequate after 4-8 weeks, should be to add oral prednisone 40 mg/day or budesonide MMX 9 mg/day as second-line therapy, according to the American Gastroenterological Association 1, 5, 2

Avoid underdosing, as doses less than 2 g/day are significantly less effective than doses ≥2 g/day, based on evidence from the Praxis Medical Insights guidelines 2
Combined oral plus rectal therapy is superior to oral alone for left-sided colitis, according to the Praxis Medical Insights guidelines 2

Delayed escalation should be avoided, and corticosteroids should be added within 40 days without improvement, based on guidelines from the Praxis Medical Insights 2
If oral 5-ASA fails, therapy should be escalated instead of switching to another oral 5-ASA formulation, as recommended by the American Gastroenterological Association 1, 4
Excessive use of antidiarrheal medications should be avoided, as it can mask worsening inflammation and theoretically increase risk of toxic dilatation, according to the Praxis Medical Insights guidelines 6

Once remission is achieved, the same therapy that induced remission should be continued, as recommended by the American Gastroenterological Association 1, 4
For maintenance, at least 2 g/day of oral mesalamine should be used, based on evidence from the American Gastroenterological Association 1, 5, 4
Corticosteroids should never be used for maintenance due to ineffectiveness and significant adverse effects with prolonged use, according to the American Gastroenterological Association 1, 5, 4

Mesalamine at 4.8 g/day is well-tolerated with adverse event rates similar to lower doses, based on evidence from the Praxis Medical Insights guidelines 2